Security readout for executives and security teams
Plain-English summary
This CVE affects SourceCodester Web-based Pharmacy Product Management System 1.0. A normal logged-in user may be able to act as an administrator and perform sensitive actions, including adding users. That can undermine account governance and expose pharmacy management data if the system is deployed in production.
Executive priority
Prioritize within normal high-severity remediation timelines, sooner for internet-facing or multi-user deployments. The main business risk is unauthorized administrative control over a pharmacy management system, which can affect data confidentiality and operational integrity.
Technical view
The issue is incorrect access control, mapped to CWE-284. CVSS 3.1 is 8.1: network exploitable, low complexity, low privileges required, no user interaction, with high confidentiality and integrity impact. The record says low-privileged users can forge high-privileged sessions and perform admin-level operations.
Likely exposure
Exposure is likely limited to organizations running SourceCodester Web-based Pharmacy Product Management System 1.0, especially if reachable over the internet or broad internal networks. The CVE bundle’s affected product metadata is incomplete, so confirm deployments by software name and version rather than CPE alone.
Exploitation context
The source bundle does not indicate CISA KEV listing or confirmed active exploitation. A public GitHub reference is listed for the vulnerability, which may increase awareness. Treat this as a serious privilege-escalation risk where untrusted or low-privileged users can access the application.
Researcher notes
Evidence is limited to the CVE description and referenced GitHub write-up. The CVE affected metadata lists n/a despite the title naming the product and version. No official patch is named in the provided sources, and KEV is false.
Mitigation direction
- Check the project or vendor source for an official patch or guidance.
- Restrict application access to trusted users and networks until remediation is confirmed.
- Review and remove unnecessary low-privileged accounts.
- Monitor for unexpected user creation or privilege changes.
- Avoid exposing the application directly to the internet where possible.
Validation and detection
- Inventory systems for SourceCodester Web-based Pharmacy Product Management System 1.0.
- Confirm whether any instance allows low-privileged authenticated access.
- Test role enforcement in a safe environment without using public exploit payloads.
- Review audit logs for new admin users or suspicious session activity.
- Track the CVE record and GitHub reference for updated remediation details.
Public sources used
Generated from the cited source records. This long-tail analysis has not been individually reviewed by a named human.
Conservative CVE-to-ATT&CK context
These mappings and lookup hints may be relevant to the vulnerability behavior, CWE, affected product, or exposure path. Glexia-inferred context is not an official MITRE, ATT&CK, CWE, or CVE Program mapping.
ATT&CK lookup starting points
Use these exact CWE pages and searches to review the Glexia ATT&CK library from this CVE's weakness and description context.
CWE-284: Authorization and privilege behavior lookup
Authorization weaknesses can support privilege escalation and valid-account review, depending on exploit path. Open the exact CWE lookup page first, then review the ATT&CK searches from that MITRE weakness context. This is a Glexia lookup hint, not an official ATT&CK mapping.
Open ATT&CK lookupCVE-2025-56274 mapping review
Open the CVE-to-ATT&CK bridge for reviewed, inferred, or future official mappings tied to this CVE.
Open ATT&CK lookup- Severity
- High
- CVSS
- 8.1 (3.1)
- Known Exploited
- No
- Published
Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:N
CNA and ADP enrichment extracted from CVE v5
These fields come from the CVE record and ADP containers, not from Glexia's Take. They preserve time-varying source decisions such as CISA SSVC, KEV status, CVSS metrics, and provider references.
SSVC decision data
CVSS vector scores
1 official scoreWe collect every scored CVSS vector available in the official CNA and ADP containers. When more than one version is present, the table keeps the source vectors side by side instead of collapsing them into the highest score.
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:N2.85.2CISA-ADPVulnerability scoring details
Base CVSS 3.1 score
8.1HighVector: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:N
Vulnerability timeline
Timeline events are normalized from CVE metadata, CNA source timelines, ADP timelines, and KEV metadata when present.
- CVE reservedCVE Program
The CVE ID was reserved by the assigning CNA.
- CVE publishedCVE Program
The CVE record was published.
- CVE updatedCVE Program
The CVE record metadata indicates this as the latest update time.
ADP provider summaries
Source materials
- CVE List V5 sourceCVE List V5
- https://github.com/Chen1-Boop/CVE/blob/main/CVE-2025-56274.mdCVE reference, mitre
Products and packages named in the record
CWE details
CWE links open Glexia weakness intelligence pages with official CWE context, developer remediation guidance, and related CVE mappings.
Improper Access Control
Improper Access Control represents a recurring weakness pattern that can create exploitable paths when design, validation, or implementation controls are missing.